Skip to content

13F-HR filed by Long Corridor Asset Management Ltd

Long Corridor Asset Management Ltd filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-12, with 20 holding rows worth $133,166,956.

Accession
0001845501-25-000002
Filed
2025-02-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 20 entries on the cover page, a total value of $133,166,956 stated on the cover page (in dollars after the unit check, H1), rows summing to $133,166,956 with VALUE read as dollars as filed, 13F file number 028-20826. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
INCYTE CORP COM45337C102Stock330,000$22,793,100dollars as filed
Alphabet Inc. Reg. Shares A02079K305COM110,000$20,823,000dollars as filed
META PLATFORMS INC CL A30303M102COM33,000$19,321,830dollars as filed
NIO INC62914VAF3NOTE 0.500% 2/015,000,000$14,812,500dollars as filedprincipal
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS120,000$10,174,800dollars as filed
American Express Company025816109COM25,000$7,419,750dollars as filed
SEA LTD81141R100SPONSORD ADS50,000$5,305,000dollars as filed
BAIDU INC SPON ADR REP A056752108ADR60,000$5,058,600dollars as filed
NEW YORK TIMES CO MTN BE CL A650111107Stock90,000$4,684,500dollars as filed
CARNIVAL CORP COMMON STOCK143658300Stock175,000$4,361,000dollars as filed
ZILLOW GROUP INC CLASS A98954M101CL A59,395$4,208,136dollars as filed
NETEASE COM INC SPONSORED ADS64110W102ADR40,000$3,568,400dollars as filed
NIO INC62914VAK2NOTE 4.625%10/15,000,000$3,452,500dollars as filedprincipal
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR18,400$3,398,664dollars as filed
WEIBO CORP SPONSORED ADR948596101ADR318,555$3,042,200dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM40,000$277,600dollars as filed
CULLINAN THERAPEUTICS INC230031106COM15,000$182,700dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM10,000$132,200dollars as filed
KURA ONCOLOGY INC COM50127T109Stock10,000$87,100dollars as filed
OMEGA THERAPEUTICS INC68217N105COMMON STOCK85,000$63,376dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001845501-25-000002this filing2025-02-12acceptance time not in the bulk data set